AU2001266274A1 - Assay techniques based on growth stage dependent expression inc. elegans - Google Patents

Assay techniques based on growth stage dependent expression inc. elegans

Info

Publication number
AU2001266274A1
AU2001266274A1 AU2001266274A AU6627401A AU2001266274A1 AU 2001266274 A1 AU2001266274 A1 AU 2001266274A1 AU 2001266274 A AU2001266274 A AU 2001266274A AU 6627401 A AU6627401 A AU 6627401A AU 2001266274 A1 AU2001266274 A1 AU 2001266274A1
Authority
AU
Australia
Prior art keywords
elegans
growth stage
techniques based
assay techniques
dependent expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266274A
Inventor
Thierry Bogaert
Philippe Verwaerde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devgen NV filed Critical Devgen NV
Publication of AU2001266274A1 publication Critical patent/AU2001266274A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • A01K67/0335—Genetically modified worms
    • A01K67/0336—Genetically modified Nematodes, e.g. Caenorhabditis elegans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
AU2001266274A 2000-06-08 2001-06-08 Assay techniques based on growth stage dependent expression inc. elegans Abandoned AU2001266274A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0014009.5A GB0014009D0 (en) 2000-06-08 2000-06-08 Compound screens relating to insulin deficiency or insulin resistance
GB0014009.5 2000-06-08
PCT/IB2001/001213 WO2001094627A2 (en) 2000-06-08 2001-06-08 Assay techniques based on growth stage dependent expression in c. elegans

Publications (1)

Publication Number Publication Date
AU2001266274A1 true AU2001266274A1 (en) 2001-12-17

Family

ID=9893260

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001266271A Abandoned AU2001266271A1 (en) 2000-06-08 2001-06-08 Compound screens relating to insulin deficiency or insulin resistance
AU2001266274A Abandoned AU2001266274A1 (en) 2000-06-08 2001-06-08 Assay techniques based on growth stage dependent expression inc. elegans

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001266271A Abandoned AU2001266271A1 (en) 2000-06-08 2001-06-08 Compound screens relating to insulin deficiency or insulin resistance

Country Status (6)

Country Link
US (2) US20050229260A1 (en)
EP (2) EP1287354A2 (en)
JP (2) JP2003534815A (en)
AU (2) AU2001266271A1 (en)
GB (1) GB0014009D0 (en)
WO (2) WO2001094627A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583836A4 (en) * 2002-12-11 2006-12-27 Univ Massachusetts METHOD OF INTRODUCING siRNA INTO ADIPOCYTES
DE10303850A1 (en) * 2003-01-30 2004-08-12 Aventis Pharma Deutschland Gmbh Screening assay based on the forkhead transcription factor dependent sod-3 promoter to identify AKT modulating compounds or upstream regulators such as insulin / IGF1 receptors
US7435868B2 (en) * 2003-01-30 2008-10-14 Sanofi-Aventis Deutschland Gmbh Screening assay based on the forkhead transcription factor-dependent sod-3 promoter
EP2402441A1 (en) 2004-04-09 2012-01-04 Monsanto Technology, LLC Compositions and methods for control of insect infestations in plants
JP5832062B2 (en) * 2005-05-31 2015-12-16 デフヘン・ナムローゼ・フェンノートシャップＤＥＶＧＥＮ ｎｖ RNAi for insect and spider control
WO2010151625A1 (en) * 2009-06-25 2010-12-29 Fred Hutchinson Cancer Research Center Methods for treating and diagnosing glucose metabolic syndrome
WO2016126026A2 (en) * 2015-02-04 2016-08-11 서울대학교병원 Composition for treating diabetes and use thereof
US10184104B2 (en) * 2015-11-19 2019-01-22 Alexander Lee Lianides Automated system for cultivating transgenic C. elegans
US10550357B2 (en) 2017-06-15 2020-02-04 The Procter & Gamble Company Water-soluble unit dose article comprising a solid laundry detergent composition
EP3415606A1 (en) 2017-06-15 2018-12-19 The Procter & Gamble Company Water-soluble unit dose article comprising a solid laundry detergent composition
EP3415601A1 (en) 2017-06-15 2018-12-19 The Procter & Gamble Company Water-soluble unit dose article comprising a solid laundry detergent composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376239B1 (en) * 1997-04-04 2002-04-23 Elegene Gmbh DNA molecules comprising a promoter capable of conferring expression of a heterologous DNA sequence
US6861256B2 (en) * 1997-05-15 2005-03-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
WO1998051351A1 (en) * 1997-05-15 1998-11-19 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
DE19727962A1 (en) * 1997-07-02 1999-01-14 Juergen Hescheler Fluorescent proteins as cell type-specific reporters

Also Published As

Publication number Publication date
US20050229260A1 (en) 2005-10-13
EP1287354A2 (en) 2003-03-05
JP2004500866A (en) 2004-01-15
JP2003534815A (en) 2003-11-25
WO2001093669A3 (en) 2002-05-10
GB0014009D0 (en) 2000-08-02
US20040073956A1 (en) 2004-04-15
WO2001094627A3 (en) 2002-10-03
EP1287353A2 (en) 2003-03-05
WO2001094627A2 (en) 2001-12-13
WO2001093669A2 (en) 2001-12-13
AU2001266271A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
AU2001236677A1 (en) Data storewidth accelerator
AU2001282890A1 (en) Immunosensor
AU2002226072A1 (en) Value-instance-connectivity-computer-implemented database
AU2002214238A1 (en) Ebook-epublishing patent novelties
AU2001290529A1 (en) Marital aid
AU2001266274A1 (en) Assay techniques based on growth stage dependent expression inc. elegans
AU2001244687A1 (en) Micro-array
AU2001264247A1 (en) GASC1 gene
AU7626201A (en) Stage construction
AU2001232041A1 (en) Improved assay
AU2001284047A1 (en) Butinol I esterase
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001282644A1 (en) Case
AU2002223788A1 (en) Tannages
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU5240901A (en) Assay
AU2002230889A1 (en) Target enzymes
AU2001287874A1 (en) Secure messaging
AU2002236595A1 (en) Enzymes
AU2001284497A1 (en) Lure
AU3292800A (en) Improved stage
AU2001276499A1 (en) Assay
AU3389501A (en) Assay
AU1181001A (en) Siphon